Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis

Journal of Dairy Research

Volumn 80, Issue 3, 2013, Pages 263-269

  Trejo, Fernando M ^a   De Antoni, Graciela L ^b,c   Pérez, Pablo F ^a,b  

^a CENTRO DE INVESTIGACIÓN Y DESARROLLO EN CRIOTECNOLOGÍA DE ALIMENTOS CIDCA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c Centro Científico y Tecnológico Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

Bifidobacterium; Clostridium difficile; enterocolitis; hamster model; probiotics

Indexed keywords

PROBIOTIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIFIDOBACTERIUM; CECUM; CHLOROCEBUS AETHIOPS; CLOSTRIDIUM DIFFICILE; DRUG EFFECT; FEMALE; HAMSTER; MESOCRICETUS; METABOLISM; MICROBIOLOGY; PATHOLOGY; PSEUDOMEMBRANOUS COLITIS; STOMACH JUICE; VERO CELL;

ANIMALS; BIFIDOBACTERIUM; CECUM; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; CRICETINAE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GASTROINTESTINAL CONTENTS; MESOCRICETUS; PROBIOTICS; VERO CELLS;

EID: 84880850101     PISSN: 00220299     EISSN: 14697629     Source Type: Journal    
DOI: 10.1017/S0022029913000216     Document Type: Article

References (37)

1. Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE & Weese JS 2005 PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. Journal of Medical Microbiology 54 163-166
2. Aslam S, Hamill RJ & Musher DM 2005 Treatment of Clostridium difficileassociated disease: old therapies and new strategies. Lancet Infectious Disease 5 549-557
3. Avberse J, Janezic S, Patee M, Rupnik M, Zidaric M, Logar K, Vengust M, Zemljic M, Pirs T & Ocepek M 2009 Diversity of Clostridium difficile in pigs and other animals in Slovenia. Anaerobe 15 252-255
4. Barth H, Aktories K, Popoff MR & Stiles BG 2004 Binary bacterial toxins: biochemistry, biology and applications of common Clostridium and Bacillus proteins. Microbiology and Molecular Biology Reviews 68 373-402
5. Buts JP 2008 Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Digestive Disease Science 54 15-18
6. Castagliuolo I, LaMont JT, Nikulasson ST & Pothoulakis C 1999 Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity 64 5225-5232
7. Chang TW, Bartlett LG, Gorbach SL & Onderdonk AB 1978 Clindamycininduced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infection and Immunity 20 526-529
8. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J & Wilcox MH 2010 Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology 31 431-455
9. Gomez Zavaglia A, Kociubinski G, Pérez PF & De Antoni GL 1998 Isolation and characterization of Bifidobacterium strains for probiotic formulation. Journal of Food Protection 61 865-873
10. Gougoulias C, Tuohy KM & Gibson GR 2007 Dietary-based gut flora modulation against Clostridium difficile onset. Food Science and Technology Bulletin: Functional Foods 4 31-41
11. Gursoy S, Guven T, Arikan K, Yurci A, Torun E, Baskol EM, Ozbakir O & YucesoyM2007 Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Hepatogastroenterology 54 1720-1724
12. Hopman NE, Keessen EC, Harmanus C, Sanders IM, van Leengoed LA, Kuijper EJ & Lipman LJ 2011 Acquisition of Clostridium difficile by piglets. Veterinary Microbiology 149 186-192
13. Jank T, Giesemann T & Aktories K 2007 Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17 15R-22
14. R Kelly CP, Pothoulakis C & LaMont JT 1994 Clostridium difficile colitis. New England Journal of Medicine 330 257-262
15. Larson HE & Borriello SP 1990 Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrobials Agents and Chemotherapy 34 1348-1353
16. Lewis S, Burmeister S & Brazier J 2005 Effect of the probiotic oligofructose on relapse of Clostridium difficile-Associated diarrhea: a randomized, controlled study. Clinical Gastroenterology and Hepatology 3 442-448
17. Limaye AP, Turgeon DK, Cookson BT & Fritsche TR 2000 Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. Journal of Clinical Microbiology 38 1696-1697
18. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DM & Rood JI 2009 Toxin B is essential for virulence of Clostridium difficile. Nature 458 1176-1179
19. Matsuki S, OzakI E, Shozu M, Inoue M, Shimizu S, Yamaguchi N, Karasawa T, Yamagishi T & Nakamura S 2005 Colonization by Clostridium difficile of neonates in a hospital and infants and children in three day-care facilities of Kanazawa, Japan. International Microbiology 8 43-48
20. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova VC, Sambol SP, Johnson S, & Gerding DN 2005 An epidemic, toxin gene-variant strain of Clostridium difficile. New England Journal of Medicine 353 2433-2441
21. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F & Hamill RJ 2005 Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clinical Infectious Diseases 40 1586-1590
22. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D & Bourassa C 2005 Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical Infectious Diseases 40 1591-1597
23. Pérez PF, Minnaard J, Disalvo EA & De Antoni GL 1998 Surface properties of bifidobacterial strains of human origin. Applied Environmental Microbiology 64 21-26
24. Plummer S, Weaver MA, Harris JC, Dee P & Hunter J 2004 Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. International Microbiology 7 59-62
25. Popoff MR, Rubin EJ, Gill DM & Boquet P 1988 Actin-specific ADPribosyltransferase produced by a Clostridium difficile strain. Infection and Immunity 56 2299-2306
26. Sambol SP, Merrigan MM, Tang JK, Johnson S & Gerding DN 2002 Colonization for the prevention of Clostridium difficile disease in hamsters. Journal of Infectious Diseases 186 1781-1789
27. Schroeder M 2005 Clostridium difficile associated diarrhea. American Family Physician 71 921-928
28. Schwan C, Stecher B, Tzivelekidis T, van Ham V, Rohde M, Hardt WD, Wehland J & Aktories K 2009 Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathogens 5 e10000626. doi: 10.1371/journal. ppat.1000626
29. Segarra-Newnham M 2007 Probiotics for Clostridium difficile associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Annals of Pharmacotherapy 41 1284-1287
30. Songer JG & Anderson MA 2006 Clostridium difficile: an important pathogen of food animals. Anaerobe 12 1-4
31. Sunenshine RH & McDonald LC 2006 Clostridium difficile-Associated disease: new challenges from an established pathogen. Cleveland Clinical Journal of Medicine 73 187-197
32. Toothaker RD & Elmer GW 1984 Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii. Antimicrobial Agents and Chemotherapy 26 552-556
33. Trejo FM, Minnaard J, Pérez PF & De Antoni GL 2006 Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 12 186-193
34. Trejo FM, Pérez PF & De Antoni GL 2010 Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Antonie van Leeuwenhoek 98 19-29
35. Waters EH, Orr JP, Clark EG & Schaufele CM 1998 Typhlocolitis caused by Clostridium difficile in suckling piglets. Journal of Veterinary Diagnostic Investigation 10 104-108
36. Wullt M, Hagslatt ML & Odenholt I 2003 Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-Associated diarrhoea: a double-blind, placebocontrolled trial. Scandinavian Journal of Infectious Diseases 35 365-367
37. Xiao JZ, Takahashi S, Odamaki T, Yaeshima T & Iwatsuki K 2010 Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Bioscience Biotechnology and Biochemistry 74 336-342 Tecnológica Técnicas Provincia de Buenos Aires